Interferon beta (Toray/Daiichi Sankyo)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta (Toray/Daiichi Sankyo)
Drug Alias NameHuIFN-βFeronDL-8234
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionInterferon-alpha/beta receptor alpha chain stimulantsImmunomodulators
TargetsInterferon-alpha/beta receptor alpha chain
Therapy Area/IndicationsMelanomaMedulloblastomaGlioblastoma +[6] 
Global Approved IndicationsMelanomaMedulloblastomaGlioblastoma +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1985/04/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesToray Industries Inc
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co LtdToray Industries Inc
Inactive CompaniesN/A
Active IndicationsMelanomaMedulloblastomaGlioblastoma +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB02
Related LinksWikipediaDrugBankKEGG